×
<- Back

148157 - Sentinel node biopsy: Implications for adjuvant therapy

  • : Online

 

A webinar for GPs and specialists covering Sentinel node biopsy and the implications for new adjuvant therapy treatments in stage 3 melanoma

Relevance to General Practice

Management of Stage III melanoma has evolved in recent years. With the advent of effective adjuvant therapy in treating Stage III melanoma, sentinel node biopsy (SNB) is essential for accurate clinical decision-making for clinicians. In this webinar, Surgical Oncologist Prof Andrew Spillane presents on the role of SNB, the current practice undertaken at Melanoma Institute Australia and the implications for adjuvant therapy. 

Learning outcomes
  • 1. Describe what is sentinel lymph node biopsy (SNB)
  • 2. Describe the benefit of SNB for melanoma patients
  • 3. Develop a systemic approach to SNB, based on latest evidence and new upcoming adjuvant treatment options for clinically occult stage 3 melanoma patients.
  •  

    Delivery
    Title
    148157 - Sentinel node biopsy: Implications for adjuvant therapy
    Location
    Duration
    1 hour
    Start Date
    23-Nov-2018
    End Date
    31-Dec-2019
    CPD
    1 hour
    Price
    0.00
    Location
    Online
    Contact Phone
    Log in into view this field.
    5 Views
    Similar Courses and Events
    HealthcareLink